You are here

AusPAR: Normal immunoglobulin (human)

Australian Public Assessment Report

13 December 2021
AusPAR Details
AusPAR
Active Ingredient
Normal immunoglobulin (human)
Product Name
Kiovig
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2020-02469-1-1
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
24 November 2021
Publication Date

13 December 2021